Inotuzumab ozogamicin Intravenous and Lorcaserin Extended-Release Tablets
Determining the interaction of Inotuzumab ozogamicin Intravenous and Lorcaserin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab ozogamicin, Inotuzumab Ozogamicin
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotuzumab ozogamicin Intravenous-Lorcaserin Hydrochloride
- Inotuzumab ozogamicin Intravenous-Lorcaserin Tablets
- Inotuzumab ozogamicin Intravenous-Lorcet
- Inotuzumab ozogamicin Intravenous-Lorcet Plus
- Inotuzumab ozogamicin Intravenous-Lorcet Tablets
- Inotuzumab ozogamicin Intravenous-Lorlatinib
- Lorcaserin Extended-Release Tablets-Inova
- Lorcaserin Extended-Release Tablets-Inova 4/1 topical
- Lorcaserin Extended-Release Tablets-Inova 8/2 topical
- Lorcaserin Extended-Release Tablets-Inova ACT
- Lorcaserin Extended-Release Tablets-Inrebic
- Lorcaserin Extended-Release Tablets-Inspra